A protoporphyrin IX derivative having a phospholipid residue (lipid-porphyrin) was synthesized. The lipid-porphyrin itself formed an oval multilamellar vesicle in an aqueous medium. The spectral features of the lipid-porphyrin vesicle indicated a stacked configuration of the porphyrin moiety.
我们合成了一种具有磷脂残基的原卟啉 IX 衍生物(脂质卟啉)。脂质卟啉本身在水介质中形成一个椭圆形的多纤层囊泡。脂质-卟啉囊泡的光谱特征表明卟啉分子呈堆叠构型。
ANTI-PAF ANTIBODIES
申请人:SABBADINI Roger A.
公开号:US20110212088A1
公开(公告)日:2011-09-01
Monoclonal antibodies to platelet activating factor (PAF) are described, along with methods for their production and use. Such antibodies can be formulated and used for therapeutic purposes, as well as for diagnosis and detection.
A new reagent for the removal of the 4-methoxybenzyl ether: application to the synthesis of unusual macrocyclic and bolaform phosphatidylcholines.
作者:Normand Hebert、Alain Beck、R. Bruce Lennox、George Just
DOI:10.1021/jo00032a033
日期:1992.3
The total synthesis of two novel polymerizable phosphatidylcholines has been accomplished using 3-(4-methoxybenzyl)-sn-glycerol 10 as starting material. Diacylation of 10 with 13-tetradecynoic acid followed by oxidative coupling of the alkynes gives the 32-membered glycerol macrocycle 17. Sequential acylation of 10 with palmitic acid and 15-hexadecynoic acid followed by oxidative coupling gives the bolaform 16, tethered at the 2-position of the glycerol. A new method for the cleavage of 4-methoxybenzyl ethers using dimethylboron bromide at -78-degrees-C in dichloromethane is described. 1,3-Diacetylenes, 1,4-dienes, and esters are stable under the experimental conditions, and the migration of acyl chains from secondary to primary positions is totally suppressed. The diacylglycerols are then efficiently converted into the corresponding phosphatidylcholines by tetrazole-catalyzed phosphitylation with 2-cyanoethyl 2-bromoethyl N,N-diisopropylamino phosphite, oxidation, and treatment with trimethylamine to simultaneously displace the bromide and eliminate the cyanoethyl group.
HEBERT, NORMAND;JUST, GEORGE, J. CHEM. SOC. CHEM. COMMUN.,(1990) N1, C. 1497-1498
Monoclonal antibodies to platelet activating factor (PAF) are described, along with methods for their production and use. Such antibodies can be formulated and used for therapeutic purposes, as well as for diagnosis and detection.